II - In-house lobbyists and trade/business/professional associations
Companies & groups
East 42nd Street, 235
New York NY 10017
Boulevard de la Plaine 17
Mr Ian C. Read
Ms Eva Grut-Aandahl
Head of EU Office
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In 2014, Pfizer's revenue was 49,6bn, with approx. 10% invested in research and development.To learn more, please visit us at www.pfizer.com.
healthcare and pharmaceutical legislation, trade & IP, competition, taxation, environment, social legislation
EU expert group on rare diseases
Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment
50%: 4 25%: 3
4 colleagues are full-time engaged in the Brussels office and will spend approx. 50% of their time on EU affairs. 3 colleagues spend about 25% of their time, and a few more colleagues spend between 0-5% of their time.
|First name||Surname||Start Date||End Date|
Pfizer is a member of: EFPIA, EBE, Vaccines Europe, EuropaBio, AESGP, Amcham EU, BusinessEurope, TPN, TABC, AECA
11/2013 - 11/2014
700,000 € - 799,999 €
No funding received from the EU institutions during the last closed financial year.
This estimate is based on the pro rata salary costs of Pfizer staff involved in interest representation to the European institutions, based on the proportion of employee time spent on these activities. A proportion of overheads for our Brussels office is included in the estimate on the same basis, as well as other costs required in the November 2014 guideline.
By its registration the organisation has signed the Transparency Register Code of Conduct.
The organisation has also declared to be bound to the following other Code:
Internal Pfizer FCPA Code and Compliance, EFPIA Codes